New at Grovet: HorStem
Since the 1st of September, Grovet has been the distributor of Horstem in the Netherlands, Germany and Poland. Horstem is the first registered veterinary medicine that consists of stem cells obtained from the umbilical cord of horses. These stem cells reduce lameness in horses with chronic inflammation of the joints (osteoarthritis). Horstem is ready-to-use, it can be injected directly into the affected joint.
In horses with osteoarthritis, Horstem inhibits the inflammatory response and the breakdown of cartilage. This reduces the horse's lameness and the clinical results last for more than a year.
Other advantages of stem cells obtained from the umbilical cord include:
· The cells are obtained non-invasively from birth tissue after birth.
